Clinical practice guidelines for identification, screening and follow-up of individuals at high risk of primary cutaneous melanoma: A systematic review

British Journal of Dermatology

Volumn 172, Issue 1, 2015, Pages 33-47

  Watts, C G ^a   Dieng, M ^a   Morton, R L ^b,c   Mann, G J ^a   Menzies, S W ^d   Cust, A E ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SCREENING; CONGENITAL NEVUS; CUTANEOUS MELANOMA; DYSPLASTIC NEVUS; FAMILY HISTORY; FOLLOW UP; HIGH RISK POPULATION; HUMAN; MELANOCYTIC NEVUS; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SELF EXAMINATION; SKIN EXAMINATION; SYSTEMATIC REVIEW; EARLY CANCER DIAGNOSIS; MELANOMA; NEVUS; PATIENT REFERRAL; RISK ASSESSMENT; RISK FACTOR; SKIN NEOPLASMS;

EARLY DETECTION OF CANCER; HUMANS; MELANOMA; NEVUS; PRACTICE GUIDELINES AS TOPIC; REFERRAL AND CONSULTATION; RISK ASSESSMENT; RISK FACTORS; SKIN NEOPLASMS;

EID: 84920765099     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.13403     Document Type: Review

References (65)

1. Australian Institute of Health and Welfare. Cancer in Australia 2010: An overview. Canberra: AIHW, 2010.
2. Erdmann F, Lortet-Tieulent J, Schüz J, et al,. International trends in the incidence of malignant melanoma 1953-2008-are recent generations at higher or lower risk? Int J Cancer 2013; 132: 385-400.
3. Balch CM, Gershenwald JE, Soong S, et al,. Final version of 2009 A.J.C.C. Melanoma Staging and Classification. J Clin Oncol 2009; 27: 6199-206.
4. Alexandrescu DT,. Melanoma costs: a dynamic model comparing estimated overall costs of various clinical stages. Dermatol Online J 2009; 15: 1.
5. Kasparian NA, McLoone JK, Butow PN,. Psychological responses and coping strategies among patients with malignant melanoma: a systematic review of the literature. Arch Dermatol 2009; 145: 1415-27.
6. Turner RM, Bell KJL, Morton RL, et al,. Optimizing the frequency of follow-up visits for patients treated for localized primary cutaneous melanoma. J Clin Oncol 2011; 29: 4641-6.
7. Francken AB, Shaw HM, Accortt NA, et al,. Detection of first relapse in cutaneous melanoma patients: implications for the formulation of evidence-based follow-up guidelines. Ann Surg Oncol 2007; 14: 1924-33.
8. Francken AB, Hoekstra HJ,. Follow-up of melanoma patients: the need for evidence-based protocols. Ann Surg Oncol 2009; 16: 804-5.
9. Sladden M, Balch C, Barzilai D, et al,. Surgical excision margins for primary cutaneous melanoma. Cochrane Database Syst Rev 2009; 4: CD004835. Review.
10. Cromwell KD, Ross MI, Xing Y, et al,. Variability in melanoma post-treatment surveillance practices by country and physician specialty: a systematic review. Melanoma Res 2012; 22: 376-85.
11. Moher D, Liberati A, Tetzlaff J, Altman DG,; the PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement. Ann Intern Med 2009; 151: 264-9.
12. OCEBM Levels of Evidence Working Group. The Oxford 2011 Levels of Evidence. Oxford Centre for Evidence-Based Medicine, 2011. Available at: http://www.cebm.net/index.aspx?o=5653 (last accessed 24 November 2014).
13. Australian Cancer Network Melanoma Guidelines Revision Working Party. Clinical Practice Guidelines for the Management of Melanoma in Australia and New Zealand. Wellington: Cancer Council Australia and Australia Cancer Network, Sydney and New Zealand Guidelines Group, 2008.
14. From L, Marrett L, Rosen C, et al,. Screening for Skin Cancer: A clinical practice guideline. Toronto: Program in Evidence-based Care (PEBC), Cancer Care Ontario (CCO), 2007.
15. BC Cancer Agency. Cancer Management Guidelines. Vancouver: BC Cancer Agency, 2013.
16. Marsden JR, Newton-Bishop JA, Burrows L, et al,. British Association of Dermatologists Clinical Standards Unit. Revised U.K. guidelines for the management of cutaneous melanoma 2010. Br J Dermatol 2010; 163: 238-56.
17. Clinical Guidelines Committee Royal College of Surgeons in Ireland. Management of Cutaneous Melanoma Clinical Guidelines. Dublin: Royal College of Surgeons in Ireland, 2006.
18. Rutkowski P, Wysocki PJ, Nowecki ZI, et al,. Cutaneous melanoma: diagnostic and therapeutic guidelines in 2013. Przegl Dermatol 2013; 100: 1-15.
19. Guidelines Working Group. National Guidelines for Diagnosis, Treatment and Follow-up of Malignant Melanomas. Oslo: Norwegian Directorate of Health, 2011.
20. Finnish Medical Society Duodecim and Chirugia Plastici Fenniaen Working Group. Ihomelanooma (Melanoma of the Skin). Helsinki: Duodecim Medical Publications Ltd, 2012.
21. Dutch Working Group on Melanoma. Melanoma Guideline 2012. Utrecht: Integraal Kankercentrum Nederland, 2013.
22. Villalobos Leõn ML, Molina Villaverde R, Lõpez González JL, Álvarez-Mon Soto M,. Melanoma. Medicine (Spain) 2013; 11: 1597-607.
23. ®) 2014. Available at: http://cancer.gov/cancertopics/pdq/genetics/skin/HealthProfessional (last accessed 24 November 2014).
24. Working Group on Adaptation of Clinical Guidelines. Melanoma. Adapted Evidence Based Clinical Guidelines. 2014. Available at: http://www.moz-derm.org.ua/uncategorized/Cyrillic small letter emCyrillic small letter ieCyrillic small letter elCyrillic small letter aCyrillic small letter enCyrillic small letter oCyrillic small letter emCyrillic small letter a-Cyrillic small letter aCyrillic small letter deCyrillic small letter aCyrillic small letter peCyrillic small letter teCyrillic small letter oCyrillic small letter veCyrillic small letter aCyrillic small letter enCyrillic small letter a-Cyrillic small letter kaCyrillic small letter elCyrillic small letter Byelorussian-Ukrainian iCyrillic small letter enCyrillic small letter Byelorussian-Ukrainian iCyrillic small letter cheCyrillic small letter enCyrillic small letter a-Cyrillic small letter enCyrillic small letter aCyrillic small letter esCyrillic small letter teCyrillic small letter aCyrillic small letter en/ (last accessed 24 November 2014).
25. Fitzpatrick T,. Soleil et peau [Sun and skin]. J Méd Esthétique 1975; 2: 33-4.
26. Institut National du Cancer (INCa) and Haute Autorité de Santé (HAS). Melanome cutane. Cedex: Haute Autorite de Sante (HAS), 2012.
27. Melanoma Advisory Board. Guideline on the Management of Melanoma. S Afr Med J 2004; 94: 699-707.
28. Scottish Intercollegiate Guidelines Network (SIGN). Cutaneous Melanoma: A national clinical guideline. Edinburgh: Scottish Intercollegiate Guidelines Network, 2003.
29. Smylie M, Claveau J, Alanen K, et al,. Canadian Expert Panel on Malignant Melanoma. Management of malignant melanoma: best practices. J Cutan Med Surg 2009; 13: 55-73.
30. National Collaborating Centre for Cancer. Improving Outcomes for People with Skin Tumours including Melanoma. London: National Institute for Health and Clinical Excellence, 2006.
31. Sowerby Centre for Health Informatics. Prodigy: Melanoma and Pigmented Lesions. 2011 (Version 1). Available at: http://prodigy.clarity.co.uk (last accessed 24 November 2014).
32. American Society of Plastic Surgeons. Evidence-based Clinical Practice Guideline: Treatment of Cutaneous Melanoma. Arlington Heights: American Society of Plastic Surgeons, 2007. Available at: http://www.plasticsurgery.org/Documents/medical-professionals/health-policy/evidence-practice/Evidence-based-Clinical-Practice-Guideline-Treatment-of-Cutaneous-Melanoma.pdf (last accessed 24 November 2014).
33. Bishop JN, Bataille V, Gavin A, et al,. The prevention, diagnosis, referral and management of melanoma of the skin: concise guidelines. Clin Med 2007; 7: 283-90.
34. U.S. Preventive Services Task Force. Screening for skin cancer: recommendation statement. Ann Intern Med 2009; 150: 188-93.
35. Mangas C, Paradelo C, Puig S, et al,. Initial evaluation, diagnosis, staging, treatment, and follow-up of patients with primary cutaneous malignant melanoma. Consensus statement of the Network of Catalan and Balearic Melanoma Centers. Actas Dermo-Sifiliogr 2010; 101: 129-42.
36. Coit DG, Thompson JA, Andtbacka R, et al,. N.C.C.N. Clinical Practice Guidelines in Oncology: Melanoma version 4. 2014. National Comprehensive Cancer Network Inc, 2014. Available at: http://www.nccn.org/professionals/physician-gls/f-guidelines.asp (last accessed 24 November 2014).
37. Pflugfelder A, Kochs C, Blum A, et al,.; German Dermatological Society; Dermatologic Cooperative Oncology Group. Malignant melanoma S3-guideline 'Diagnosis, Therapy and Follow-up of Melanoma'. J Dtsch Dermatol Ges 2013; 11 (Suppl. 6): 1-116.
38. Garbe C, Peris K, Hauschild A, et al,. Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline-update 2012. Eur J Cancer 2012; 48: 2375-90.
39. Quaglino P, Borgognoni L, Bottoni U, et al.; from the Gruppo Italiano di Dermatologia Oncologica (GIDO), the Gruppo Italiano Polidisciplinare sul Melanoma (GIPMe). Italian guidelines for staging and follow-up of stage I-II cutaneous melanoma patients. Ital J Dermatol Venereol 2007; 142: 41-7.
40. Bichakjian CK, Halpern AC, Johnson TM, et al,. American Academy of Dermatology. Guidelines of care for the management of primary cutaneous melanoma. American Academy of Dermatology. J Am Acad Dermatol 2011; 65: 1032-47.
41. Zalaudek I, Argenziano G, Ferrara G, et al,. Melanoma. Guidelines for diagnosis and therapy [Das melanom. Richtlinien für diagnose und therapie. Journal name is Tagliche Praxis]. Tagliche Praxis 2005; 46: 35-52.
42. Dummer R, Hauschild A, Guggenheim M, et al,. ESMO Guidelines Working Group. Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2012; 23 (Suppl. 7): 86-91.
43. Menzies SW, Emery J, Staples M, et al,. Impact of dermoscopy and short-term sequential digital dermoscopy imaging for the management of pigmented lesions in primary care: a sequential intervention trial. Br J Dermatol 2009; 161: 1270-7.
44. New Zealand Guidelines Group (NZGG). Suspected Cancer in Primary Care. Guidelines for Investigation, Referral and Reducing Ethnic Disparities. Wellington, New Zealand: Wellington Ministry of Health, 2009.
45. Saiag P, Bosquet L, Guillot B, et al. Société Française de Dermatologie. Management of adult patients with cutaneous melanoma without distant metastasis. 2005 update of the French Standards, Options and Recommendations guidelines. Summary report. Eur J Dermatol 2007; 17: 325-31.
46. Tovo LF, Belfort FA, Sanches JA Jr,; Brazilian Society of Dermatology. [ Primary cutaneous melanoma ]. Rev Assoc Med Bras 2005; 51: 7-8 (in Portuguese).
47. Alberta Provincial Cutaneous Tumour Team. Referral and Follow-up Surveillance of Cutaneous Melanoma. Edmonton, Alberta: Alberta Health Services, 2011.
48. Dummer R, Guggenheim M, Arnold AW, et al,. Updated Swiss guidelines for the treatment and follow-up of cutaneous melanoma. Swiss Med Wkly 2011; 141: w13320.
49. Banky JP, Kelly JW, English DR, et al,. Incidence of new and changed nevi and melanomas detected using baseline images and dermoscopy in patients at high risk for melanoma. Arch Dermatol 2005; 141: 998-1006.
50. Hansson J, Bergenmar M, Hofer PA, et al,. Monitoring of kindreds with hereditary predisposition for cutaneous melanoma and dysplastic nevus syndrome: results of a Swedish preventive program. J Clin Oncol 2007; 25: 2819-24.
51. Salerni G, Lovatto L, Carrera C, et al,. Melanomas detected in a follow-up program compared with melanomas referred to a melanoma unit. Arch Dermatol 2011; 147: 549-55.
52. Goodson AG, Florell SR, Hyde M, et al,. Comparative analysis of total body and dermatoscopic photographic monitoring of nevi in similar patient populations at risk for cutaneous melanoma. Dermatol Surg 2010; 36: 1087-98.
53. Rice Z, Weiss F, DeLong L, et al,. Utilization and rationale for the implementation of total body (digital) photography as an adjunct screening measure for melanoma. Melanoma Res 2010; 20: 417-21.
54. Argenziano G, Mordente I, Ferrara G, et al,. Dermoscopic monitoring of melanocytic skin lesions: clinical outcome and patient compliance vary according to follow-up protocols. Br J Dermatol 2008; 159: 331-6.
55. O'Donnell AT, Kim CC,. Update and clinical use of imaging technologies for pigmented lesions of the skin. Semin Cutan Med Surg 2012; 31: 38-44.
56. Salerni G, Carrera C, Lovatto L, et al,. Characterization of 1152 lesions excised over 10 years using total-body photography and digital dermatoscopy in the surveillance of patients at high risk for melanoma. J Am Acad Dermatol 2012; 67: 836-45.
57. Moloney FJ, Guitera P, Coates E, et al,. Detection of primary melanoma in individuals at extreme high risk: a prospective 5-year follow-up study. JAMA Dermatol 2014; 150: 819-27.
58. Poonacha TK, Go RS,. Level of scientific evidence underlying recommendations arising from the National Comprehensive Cancer Network clinical practice guidelines. J Clin Oncol 2011; 29: 186-91.
59. Guyatt G, Rennie D, eds and The Evidence-Based Medicine Working Group. Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice. Chicago: AMA Press, 2002.
60. Hengge UR, Wallerand A, Stutzki A, et al,. Cost-effectiveness of reduced follow-up in malignant melanoma. J Dtsch Dermatol Ges 2007; 5: 898-907.
61. Moore Dalal K, Zhou Q, Panageas KS, et al,. Methods of detection of first recurrence in patients with stage I/I.I primary cutaneous melanoma after sentinel lymph node biopsy. Ann Surg Oncol 2008; 15: 2206-14.
62. Fisher NM, Schaffer JV, Berwick M, et al,. Breslow depth of cutaneous melanoma: impact of factors related to surveillance of the skin, including prior skin biopsies and family history of melanoma. J Am Acad Dermatol 2005; 53: 393-406.
63. DiFronzo LA, Wanek LA, Morton DL,. Earlier diagnosis of second primary melanoma confirms the benefits of patient education and routine postoperative follow-up. Cancer 2001; 91: 1520-4.
64. Ferrandiz L, Ruiz-de-Casas A, Martin-Gutierrez FJ, et al,. Effect of teledermatology on the prognosis of patients with cutaneous melanoma. Arch Dermatol 2012; 148: 1025-8.
65. Pollitt RA, Geller AC, Brooks DR, et al,. Efficacy of skin self-examination practices for early melanoma detection. Cancer Epidemiol Biomarkers Prev 2009; 18: 3018-23.